Drug Profile
Factor IX - China Biologic Products
Alternative Names: Human coagulation factor IX - China Biologic ProductsLatest Information Update: 28 Sep 2022
Price :
$50
*
At a glance
- Originator China Biologic Products
- Class Antihaemorrhagics; Blood coagulation factors
- Mechanism of Action Blood coagulation factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Haemophilia B
Most Recent Events
- 28 Sep 2022 Registered for Haemophilia B in China (Parenteral) prior to September 2022 (China Biologic Products website, September 2022)
- 20 Aug 2020 Factor IX is in preregistration phase for Haemophilia B in China (China Biologic Products pipeline, August 2020)
- 17 Aug 2020 Preregistration for Haemophilia B in China (Parenteral) before August 2020 (China Biologic Products pipeline, August 2020)